Susceptibility of Ceftolozane-Tazobactam and Ceftazidime-Avibactam Against a Collection of β-Lactam-Resistant Gram-Negative Bacteria.
10.3343/alm.2017.37.2.174
- Author:
Mark D GONZALEZ
1
;
Allison R MCMULLEN
;
Meghan A WALLACE
;
Matthew P CROTTY
;
David J RITCHIE
;
Carey Ann D BURNHAM
Author Information
1. Department of Pathology and Immunology, Division of Laboratory and Genomic Medicine, Washington University School of Medicine, St. Louis, MO, USA. mark.gonzalez@choa.org
- Publication Type:Brief Communication ; Letter
- MeSH:
Anti-Bacterial Agents/*pharmacology;
Azabicyclo Compounds/*pharmacology;
Bacterial Proteins/genetics;
Ceftazidime/*pharmacology;
Cephalosporins/*pharmacology;
DNA, Bacterial/genetics/metabolism;
Drug Resistance, Bacterial/*drug effects;
Gram-Negative Bacteria/drug effects/*isolation & purification;
Humans;
Microbial Sensitivity Tests;
Penicillanic Acid/*analogs & derivatives/pharmacology;
Pseudomonas aeruginosa/drug effects/isolation & purification;
Real-Time Polymerase Chain Reaction
- From:Annals of Laboratory Medicine
2017;37(2):174-176
- CountryRepublic of Korea
- Language:English
-
Abstract:
No abstract available.
